Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1993 May 1;148(9):1489–1495.

Antituberculous drug resistance in Manitoba from 1980 to 1989.

R Long 1, J Manfreda 1, L Mendella 1, J Wolfe 1, S Parker 1, E Hershfield 1
PMCID: PMC1491866  PMID: 8477367

Abstract

OBJECTIVES: To estimate the magnitude of antituberculous drug resistance and identify the risk factors for its development in tuberculosis patients in Manitoba over a 10-year period. As well, to examine the clinical course of the patients whose initial or subsequent isolates of Mycobacterium tuberculosis were resistant to one or more drugs. DESIGN: Comparison of drug-resistant and non-drug-resistant cases of tuberculosis. SETTING: Manitoba. PATIENTS: All people with tuberculosis reported to the Central Tuberculosis Registry of Manitoba between Jan. 1, 1980, and Dec. 31, 1989. MAIN OUTCOME MEASURES: Of 1478 cases of active tuberculosis 1086 were culture positive, and drug susceptibility testing was performed in these cases. The clinical course, including outcome of treatment, of all drug-resistant cases was described. RESULTS: Of 1086 culture-positive cases of tuberculosis 77 (7.1%) were drug resistant. Odds ratios suggested that the risk of drug resistance was significantly higher among the immigrants than among the other Canadians. Compared with the other Canadians the risk of drug resistance was 9.9 times greater among the immigrants in whom tuberculosis developed within the first year after arrival in Canada and 5.4 times greater among the immigrants in whom it developed 2 to 5 years after arrival in Canada. Of the 71 patients with drug-resistant disease whose type of resistance was known 62% had never taken antituberculous drugs before and 38% had. Most (91%) of the 77 cases of drug-resistant disease were resistant to first-line drugs, especially isoniazid and streptomycin. Thirty-two (42%) of the 77 cases were resistant to two or more first-line drugs. Of patients with drug-resistant disease a subgroup of 10 had disease that became resistant to several drugs over the 10-year period. The outcome of treatment in these individuals was poor, and they presented a particular public health problem. CONCLUSION: Resistance to one or more first-line antituberculous drugs continues to complicate the treatment of tuberculosis and may facilitate the spread of the disease.

Full text

PDF
1495

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong A. R. The prevalence in Canada of drug-resistant tubercle bacilli in newly discovered untreated patients with tuberculosis. Can Med Assoc J. 1966 Feb 26;94(9):420–425. [PMC free article] [PubMed] [Google Scholar]
  2. Chawla P. K., Klapper P. J., Kamholz S. L., Pollack A. H., Heurich A. E. Drug-resistant tuberculosis in an urban population including patients at risk for human immunodeficiency virus infection. Am Rev Respir Dis. 1992 Aug;146(2):280–284. doi: 10.1164/ajrccm/146.2.280. [DOI] [PubMed] [Google Scholar]
  3. Crofton J. The prevention and management of drug-resistant tuberculosis. Bull Int Union Tuberc Lung Dis. 1987 Mar-Jun;62(1-2):6–11. [PubMed] [Google Scholar]
  4. Daley C. L., Small P. M., Schecter G. F., Schoolnik G. K., McAdam R. A., Jacobs W. R., Jr, Hopewell P. C. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med. 1992 Jan 23;326(4):231–235. doi: 10.1056/NEJM199201233260404. [DOI] [PubMed] [Google Scholar]
  5. Di Perri G., Cruciani M., Danzi M. C., Luzzati R., De Checchi G., Malena M., Pizzighella S., Mazzi R., Solbiati M., Concia E. Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet. 1989 Dec 23;2(8678-8679):1502–1504. [PubMed] [Google Scholar]
  6. Eidus L., Jessamine A. G., Hershfield E. S., Helbecque D. M. A national study to determine the prevalence of drug resistance in newly discovered previously untreated tuberculosis patients as well as in retreatment cases. Can J Public Health. 1978 Mar-Apr;69(2):146–153. [PubMed] [Google Scholar]
  7. Enarson D. A., Grzybowski S., Dorken E. Failure of diagnosis as a factor in tuberculosis mortality. Can Med Assoc J. 1978 Jun 24;118(12):1520–1522. [PMC free article] [PubMed] [Google Scholar]
  8. Enarson D. A., Grzybowski S. Incidence of active tuberculosis in the native population of Canada. CMAJ. 1986 May 15;134(10):1149–1152. [PMC free article] [PubMed] [Google Scholar]
  9. Enarson D., Ashley M. J., Grzybowski S. Tuberculosis in immigrants to Canada. A study of present-day patterns in relation to immigration trends and birthplace. Am Rev Respir Dis. 1979 Jan;119(1):11–18. doi: 10.1164/arrd.1979.119.1.11. [DOI] [PubMed] [Google Scholar]
  10. Fischl M. A., Uttamchandani R. B., Daikos G. L., Poblete R. B., Moreno J. N., Reyes R. R., Boota A. M., Thompson L. M., Cleary T. J., Lai S. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med. 1992 Aug 1;117(3):177–183. doi: 10.7326/0003-4819-117-3-177. [DOI] [PubMed] [Google Scholar]
  11. Fox W. Compliance of patients and physicians: experience and lessons from tuberculosis-I. Br Med J (Clin Res Ed) 1983 Jul 2;287(6384):33–35. doi: 10.1136/bmj.287.6384.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Iseman M. D., Madsen L. A. Drug-resistant tuberculosis. Clin Chest Med. 1989 Sep;10(3):341–353. [PubMed] [Google Scholar]
  13. Iseman M. D., Sbarbaro J. A. Compliance and tuberculosis treatment. Lancet. 1991 Jun 29;337(8757):1609–1609. doi: 10.1016/0140-6736(91)93306-t. [DOI] [PubMed] [Google Scholar]
  14. Sbarbaro J. A. Compliance: inducements and enforcements. Chest. 1979 Dec;76(6 Suppl):750–756. doi: 10.1378/chest.76.6_supplement.750. [DOI] [PubMed] [Google Scholar]
  15. Scalcini M., Carré G., Jean-Baptiste M., Hershfield E., Parker S., Wolfe J., Nelz K., Long R. Antituberculous drug resistance in central Haiti. Am Rev Respir Dis. 1990 Sep;142(3):508–511. doi: 10.1164/ajrccm/142.3.508. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES